Recruiting FMT Studies - Designer Shit Documentary

Study Name	Study Focus	Location	Who’s doing the study?
FMT for MDRO Colonization in Solid Organ Transplant	Infection Due to Resistant Organism	Miami, FL, USA	University of Miami
The ICON Study: Outcomes after FMT for Patients with IBD and CDI	Inflammatory Bowel Diseases Clostridium Difficile Infection	Boston, MA, USA	Brigham and Women’s Hospital
Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy	Melanoma Stage IV Unresectable Stage III Melanoma	Tel HaShomer, Israel	Sheba Medical Center
Fecal Microbiota Transplantation (FMT) for the Treatment of Obesity	Obesity	Boston, MA, USA	Brigham and Women’s Hospital
FMT in Pediatric Crohn’s Disease	Crohn Disease Pediatric Crohns Disease	Los Angeles, CA, USA	Children’s Hospital Los Angeles
FMT Treating Constipation Patients with Depression and/or Anxiety Symptoms-Clinical Efficacy and Potential Mechanisms	Constipation-Functional Depressive Symptoms Anxiety Symptoms Gut-Brain Disorders	Jiangsu, China	Jianfeng Gong
Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Bipolar Disorder	Bipolar Depression	Toronto, ON, Canada	Valerie Taylor
A Novel Faecal Microbiota Transplantation System for Treatment of Primary and Recurrent Clostridium Difficile Infection	Clostridium Difficile Infection	Miskolc Debrecen Nyiregyhaza, Hungary	Sejtterapia Kozpont Kft
FMT for Multidrug Resistant Organism Reversal	Infection with Multi-drug Resistant Organisms	St. Louis, MO, USA	Washington University School of Medicine
The GRAFT Study: Gut Recolonization by Fecal Transplantation	Clostridium Difficile Infection	Madison, WI, USA	University of Wisconsin, Madison
Fecal Microbiota Transplantation (FMT) for the Treatment of Refractory Graft Versus Host Disease-a Pilot Study	Fecal Microbiota Transplantation in GVHD	Shanghai, China	Shanghai Children’s Medical Center
Fecal Microbiota Transplantation (FMT) for MDRO UTI	Urinary Tract Infections	St. Louis, MO, USA	Washington University School of Medicine
Pilot Study Using Oral Capsule FMT to Decolonize GI CRE	Enterobacteriaceae Infections	Los Angeles, CA, USA	Zachary A. Rubin, MD
Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection Not Responding to Antibiotics	Clostridium Difficile	Chapel Hill, NC, USA	University of North Carolina, Chapel Hill
Fecal Transplantation for Chronic Pouchitis – A Pilot Study	Ulcerative Colitis Pouchitis	Aalborg, Denmark	Aalborg Universitetshospital
Prevention of Recurrence of Crohn’s Disease by Fecal Microbiota Therapy	Crohn’s Disease	Boston, MA, USA	Beth Israel Deaconess Medical Center
Capsulized Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis Patients	Ulcerative Colitis	Zerifin, Israel	Assaf-Harofeh Medical Center
Autologous Fecal Microbiota Transplantation for Patients With Acute Graft-versus-Host Disease	Graft vs. Host Disease	Haifa, Israel	Rambam Health Care Campus
The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis	Ulcerative Colitis	Los Angeles, CA, USA	Children’s Hospital Los Angeles
Fecal Microbiota Transplantation for Decompensated Cirrhosis	Decompensated Cirrhosis	Chengdu, China	First Affiliated Hospital of Chengdu Medical College
Fecal Transplantation in Ulcerative Colitis	Ulcerative Colitis	Helsinki, Finland	Joint Authority for Paijat-Hame Social and Health Care
A Prospective Trial of Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection	Clostridium Difficile Infection	Victoria, BC Hamilton, ON Toronto, ON, Canada	McMaster University
Fecal Transplant for Crohn’s Disease	Crohn’s Disease	Calgary, AB Edmonton, AB Hamilton, ON, Canada	University of Alberta
MicroTrans – A Multicenter Registry of Fecal Microbiota Transplantation	Clostridium Infections	Cologne, Germany	University of Cologne
Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection	C. Difficile Infection Cancer	New York, NY, USA	Memorial Sloan Kettering Cancer Center
Fecal Microbiota Transplantation for the Treatment of Recurrent Urinary Tract Infections	Recurrent Urinary Tract Infection	Orange, CA, USA	University of California, Irvine
Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection	Clostridium Difficile	Columbus, OH, USA	Jonathan Gisser
Fecal Microbiota Transplantation for CRE/VRE	Antimicrobial Resistance Colonization	Sha Tin, Hong Kong	Chinese University of Hong Kong
Fecal Transplant for Hepatic Encephalopathy	Hepatic Encephalopathy	Edmonton, AB, Canada	University of Alberta
Fecal Microbiota Transplantation National Registry	Clostridium Difficile Infection Gut Microbiome	USA	American Gastroenterological Association
FMT in Inflammatory Bowel Disease	Faecal Microbiota Transplantation Crohn Disease Ulcerative Colitis Microscopic Colitis	Melbourne, Australia	St Vincent’s Hospital Melbourne
Fecal Microbiota Transplantation for C. Diff Infection in Solid Organ Transplant Recipients	Clostridium Difficile Infection Recurrence	Madison, WI, USA	University of Wisconsin, Madison
Fecal Microbiota Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis	Clostridium Difficile Infection Ulcerative Colitis Indeterminate Colitis	Stony Brook, NY, USA	Stony Brook University
FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI	Clostridium Difficile Infection	Evanston, IL, USA	NorthShore University HealthSystem
Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis	Relapsing Remitting Multiple Sclerosis	San Francisco, CA, USA	University of California, San Francisco
Standardized Fecal Microbiota Transplantation for Ulcerative Colitis	Ulcerative Colitis	Nanjing, China	The Second Hospital of Nanjing Medical University
Randomised Placebo-controlled Study of FMT to Impact Body Weight and Glycemic Control in Obese Subjects With T2DM	Type 2 Diabetes Type 2 Diabetes Mellitus Obesity	Sha Tin, Hong Kong	Chinese University of Hong Kong
Fecal Microbiota Transplantation (FMT) in Pediatric Active Ulcerative Colitis	Ulcerative Colitis	Boston, MA, USA	Stacy A. Kahn
Fecal Microbiota Transplantation (FMT) in Pediatric Active Crohn’s Colitis	Crohn’s Disease	Boston, MA, USA	Stacy A. Kahn
Fecal Microbiota Transplantation (FMT) for Severe Acute Pancreatitis	Acute Pancreatitis	Chengdu, China	First Affiliated Hospital of Chengdu Medical College
Fecal Microbiota Transplantation as a Strategy to Eradicate Resistant Organisms	Infection Resistant to Drugs	Seattle, WA, USA	Seattle Children’s Hospital
Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis (NASH). A Pilot Study	Nonalcoholic Fatty Liver Disease	Providence, RI, USA	Lifespan
Fecal Microbiota Transplantation (FMT) in Melanoma Patients	Melanoma	Pittsburgh, PA, USA	Zarour, Hassane, MD
FMT for Patients with IBS With Fecal and Mucosal Microbiota Assessment	Irritable Bowel Syndrome	Sha Tin, Hong Kong	Chinese University of Hong Kong
The FAIS-Trial: Faecal Transplantation in Adolescents With Refractory Irritable Bowel Syndrome	Irritable Bowel Syndrome	Amsterdam, Netherlands	Academisch Medisch Centrum – Universiteit van Amsterdam (AMC-UvA)
Fecal Microbiota Transplantation for Steroid Resistant and Steroid Dependant Gut Acute Graft Versus Host Disease	Stem Cell Transplant Complications Graft Versus Host Disease, Acute	Ramat Gan, Israel	Sheba Medical Center
Fecal Microbiota Transplantation for Ulcerative Colitis	Ulcerative Colitis	Chengdu, China	First Affiliated Hospital of Chengdu Medical College
Restoration of the Microbiome Through Superdonor Selection	Ulcerative Colitis	Leuven, Belgium	Universitaire Ziekenhuizen Leuven
Fecal Microbiota Transplantation in the Treatment of Pouchitis	Pouchitis Ulcerative Colitis	Helsinki, Finland	Helsinki University Central Hospital
Faecal Microbiota Transplantation in Patients with Microscopic Colitis	Microscopic Colitis	Orebro, Sweden	Orebro University, Sweden
Efficacy and Safety of Fecal Microbiota Transplantation for Slow Transit Constipation	Slow Transit Constipation	Nanjing, China	Jinling Hospital
Fecal Microbiota Transplantation for Chronic Functional Constipation	Chronic Functional Constipation	Chengdu, China	First Affiliated Hospital of Chengdu Medical College
FMT for MDRO Colonization After Infection in Renal Transplant Recipients	Infection Due to Resistant Organism	Atlanta, GA, USA	Emory University
A Prospective Trial of Frozen-and-Thawed Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection	Clostridium Difficile	Vancouver, BC Hamilton, ON Kingston, ON, Canada	McMaster University
Evaluating the Safety and Efficacy of Fecal Microbiota Transplant in Peanut Allergic Patients	Peanut Allergy	Boston, MA, USA	Rima Rachid
Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure	Acute on Chronic Liver Failure	New Delhi, India	Institute of Liver and Biliary Sciences, India
Fecal Microbiota Transplantation for Pancreatitis	Acute Pancreatitis	Nanchang, China	The First Affiliated Hospital of Nanchang University
Fecal Microbiota Transplantation for Pancreatitis With Infectious Complications	Acute Pancreatitis	Nanchang, China	The First Affiliated Hospital of Nanchang University
Fecal Microbiota Transplantation in the Management of Hepatic Encephalopathy: a Pilot Study	Hepatic Encephalopathy	Edmonton, AB, Canada	University of Alberta
Fecal Transplant for MDR Pathogen Decolonization	Multi-antibiotic Resistance	Vancouver, BC, Canada	University of British Columbia
Trial of Faecal Microbiota Transplantation in Cirrhosis	Cirrhosis of the Liver	London, UK	King’s College London
Fecal Microbiota Transplantation for Pouchitis	Pouchitis	Hamilton, ON, Canada	McMaster University
Fecal Microbiota Transplantation Improves Nutritional State of Patients with Crohn’s Disease	Crohn’s Diseases	Nanjing, China	The Second Hospital of Nanjing Medical University
Standardized Fecal Microbiota Transplantation for Crohn’s Diseases	Crohn’s Diseases	Nanjing, China	The Second Hospital of Nanjing Medical University
Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection	Clostridium Difficile Infection	Orange, CA, USA	University of California, Irvine
A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS	Irritable Bowel Syndrome	Boston, MA, USA	Anthony Lembo
Fecal Microbiota Transplantation in Depression	Major Depressive Disorder	Basel, Switzerland	Psychiatric Hospital of the University of Basel
Impact of Fecal Microbiota Transplantation in Ulcerative Colitis (REBALANCE-UC)	Ulcerative Colitis	Paris, France	Assistance Publique – Hopitaux de Paris
Fecal Microbiota Transplantation for Epilepsy	Epilepsy	Nanjing, China	The Second Hospital of Nanjing Medical University
Fecal Microbiota Transplantation for Eradication of CRE	Antibiotic Resistant Strain Microbial Colonization	Israel	Rambam Health Care Campus
Fecal Microbiota Transplantation in Ulcerative Colitis	Ulcerative Colitis	Zerifin, Israel	Assaf-Harofeh Medical Center
Fecal Microbiota Transplantation for Analysis of Fecal Microbiome in IBD Patients	Inflammatory Bowel Diseases	Seoul, Korea	Yonsei University
Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis	Ulcerative Colitis	Hamilton, ON, Canada	Hamilton Health Sciences Corporation
Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization	Antibiotic Resistant Strain Microbial Colonization	Israel	Rambam Health Care Campus
The Gut-Brain Study	Autism Spectrum Disorder Gastro-Intestinal Disorder	Los Angeles, CA, USA	Children’s Hospital Los Angeles
Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel Disease	Ulcerative Colitis Crohn Disease Constipation (Excl Faecal Impaction)	Ankara, Turkey	Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection	Clostridium Difficile Infection	Aarhus, Denmark	University of Aarhus
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile	Clostridium Difficile Infection Recurrence Clostridium Difficile Infection	Worcester, MA, USA	University of Massachusetts, Worcester
Faecal Bacteriotherapy for Ulcerative Colitis	Ulcerative Colitis	Ceske Budejovice Ostrava-Vitkovice Olomouc Prague, Czechia	Institute for Clinical and Experimental Medicine
Pilot Study of Fecal Transplantation Using a Unique Diet for Donor and Recipient in Mild to Moderate Treatment Refractory Colitis in Inflammatory Bowel Disease	Ulcerative Colitis	Paris, France Holon Tel Aviv, Israel Milan Rome, Italy	Wolfson Medical Center
Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea	Clostridium Difficile	St. John’s NL, Canada	Memorial University of Newfoundland
Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated Diarrhea	Recurrent C. Difficile Associated Diarrhea	Houston, TX, USA	The University of Texas Health Science Center, Houston
Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route	C. Difficile	Houston, TX, USA	The University of Texas Health Science Center, Houston
Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis	Ulcerative Colitis	San Francisco, CA, USA	Najwa Elnachef
Fecal Microbiota Transplantation for Irritable Bowel Syndrome	Irritable Bowel Syndrome	Guangzhou, China	Guangzhou First People’s Hospital
Faecal Microbiota Transplantation in Obesity	Obesity, Morbid	Helsinki Lahti, Finland	Joint Authority for Paijat-Hame Social and Health Care
SHIFT: Studying HIV Immunology After Fecal Transplant	HIV/AIDS	Boston, MA, USA	Massachusetts General Hospital
Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic Arthritis (FLORA)	Psoriatic Arthritis	Odense Silkeborg, Denmark	Odense University Hospital
Efficacy and Safety of Fecal Microbiota Transplantation for Severe Clostridium Difficile Associated Colitis	Clostridium Difficile	Jerusalem, Israel	Hadassah Medical Organization
Safety of FMT Using Oral Encapsulated PRIM-DJ2727 in HIV	HIV-1-infection	Houston, TX, USA	The University of Texas Health Science Center, Houston
Fecal Microbiota Transplantation in Patients With Ulcerative Colitis	Ulcerative Colitis	Turku, Finland	Turku University Hospital
Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing	Ulcerative Colitis	Nanjing, China	The Second Hospital of Nanjing Medical University
Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea	Active C. Difficile Colitis	Houston, TX, USA	Baylor College of Medicine
Randomized Controlled Trial of Fecal Microbiota Transplantation in Severe Obesity	Obesity, Morbid	Tromso Toronto, ON, Canada	University Hospital of North Norway
Evaluation of Heterologous Fecal Microbiota Transfer in ICU Patients: a Feasibility and Safety Study	Intenstive Care Units Fecal Microbiota Transplantation	Lille Paris, France	MaaT Pharma
Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home	Clostridium Difficile Infection	Minneapolis, MN, USA	VA Office of Research and Development
A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis	Severe Alcoholic Hepatitis	New Delhi, India	Institute of Liver and Biliary Sciences, India
Selective Microbiota Transplantation for Radiation Enteritis	Radiation Enteritis	Nanjing, China	The Second Hospital of Nanjing Medical University
Transfer of Healthy Gut Flora for Restoration of Intestinal Microbiota Via Enema for Severe Acute Malnutrition	Severe Acute Malnutrition	Cape Town, South Africa	Microbiome Health Research Institute
Fecal Microbial Transplantation in Patients With Crohn’s Disease	Crohn Disease	Stony Brook, NY, USA	Stony Brook University
Microbial Restoration for Individuals With One or More Recurrences of Clostridium Difficile Associated Disease	Clostridium Difficile Infection	Decatur, GA Durham, NC Nashville, TN, USA	National Institute of Allergy and Infectious Diseases
Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy	Hepatic Encephalopathy	Boston, MA, USA	Massachusetts General Hospital
Stool Transplants to Treat Refractory Clostridium Difficile Colitis	Clostridium Difficile Colitis	Durham, NC, USA	Duke University
Treatment of Steroid Refractory Gastro-intestinal Acute GVHD After Allogeneic HSCT With Fecal Microbiota Transfer	Fecal Microbiota Transplantation	Paris Pierre-Benite, France	MaaT Pharma
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection	Enterocolitis Recurrent Clostridium Difficile Infection	Edmonton, AB, Canada	Dina Kao
Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections	Clostridium Difficile	Hvidovre Koge, Denmark	Hvidovre University Hospital
Fecal Microbiota Transplantation for C Diff Infection	Clostridium Difficile Infection	Englewood, NJ, USA	Englewood Hospital and Medical Center
A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment Program	Clostridium Difficile Infection	Atlanta, GA Decatur, GA, USA	Emory University
Fecal Microbiota Transplantation in Gut aGVHD Treated	Acute-graft-versus-host Disease	Jiangsu, China	The First Affiliated Hospital of Soochow University
Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea	Irritable Bowel Syndrome	Shanghai, China	Shanghai Zhongshan Hospital
Fecal Transplant, a Hope to Eradicate Colonization of Patient Harboring Extreme Drug Resistant Bacteria	Microbial Colonization Bacterial Peritonitis Faeces Smearing	Garches, France	Centre d’Investigation Clinique et Technologique 805
Immune Response to FMT for C. Difficile	Clostridium Difficile	Charlottesville, VA, USA	University of Virginia
Fecal Microbial Transplantation and Fiber Supplementation in Participants with Obesity and Metabolic Syndrome	Obesity Metabolic Syndrome	Edmonton, AB, Canada	University of Alberta
PediCraft: Pediatric Crohn’s Disease Fecal Transplant Trial	Crohn Disease Pediatric Crohns Disease Inflammatory Bowel Diseases Colitis	Hamilton, ON, Canada	McMaster Children’s Hospital
Fresh Versus Frozen Stool for Fecal Transplant in Children	Clostridium Difficile	Rochester, MN, USA	Mayo Clinic
A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization	Antibiotic Resistant Strain	Indianapolis, IN Madison, WI, USA	Microbiome Health Research Institute
Pediatric Fecal Microbiota Transplant for Ulcerative Colitis	Ulcerative Colitis	Hamilton, ON London, ON Montreal, PQ, Canada	McMaster Children’s Hospital
Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection	Recurrent C. Difficile Infection	Houston, TX, USA	The University of Texas Health Science Center, Houston
Cesarean Section and Intestinal Flora of the Newborn	C Sections – Intestinal Microbiome	Helsinki, Finland	Sture Andersson
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection	Clostridium Difficile Infection	Halifax, NS, Canada	Queen Elizabeth II Health Sciences Centre
Fecal Microbiome Transplant	Clostridium Difficile Inflammatory Bowel Disease Crohn’s Disease Ulcerative Colitis	Philadelphia, PA, USA	Children’s Hospital of Philadelphia
Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis	Cirrhosis Alcohol Abuse	Richmond, VA, USA	Hunter Holmes Mcguire Veteran Affairs Medical Center
Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors	Acute Myeloid Leukemia	Seoul, Korea	Byung-Sik Cho
Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients	Autoimmune Diseases Relapsing Multiple Sclerosis	London, ON, Canada	Lawson Health Research Institute
Methods of Colonic Transendoscopic Enteral Tubing: a Multicenter, Open-label, Randomized Controlled Trial	Colonic Transendoscopic Enteral Tubing	Jiangsu, China	The Second Hospital of Nanjing Medical University
Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial	NASH Related Decompensated Cirrhosis	New Delhi, India	Institute of Liver and Biliary Sciences, India
Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia	Immune Thrombocytopenia	Jinan, China	Shandong University
To Assess the Role of Fecal Microbiota Transplant in Acute Liver Failure	Acute Liver Failure	New Delhi, India	Institute of Liver and Biliary Sciences, India
The Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis	Pouchitis	Nantes, France	Nantes University Hospital
Incidence and Economic Burden of Clostridium Difficile Infections in the German Health Care System	Clostridium Difficile Infection Clostridium Difficile Diarrhea	Munich Magdeburg Jena Cologne Hamburg, Germany	University of Cologne
Essential Tremor in Children and Adolescent	Essential Tremor	Montpellier, France	University Hospital, Montpellier
Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis	Non Alcoholic Steatohepatitis	New Delhi, India	Institute of Liver and Biliary Sciences, India
Feasibility and Safety of Transendoscopic Enteral Tubing in Mid-gut	Transendoscopic Enteral Tubing	Nanjing, China	The Second Hospital of Nanjing Medical University
Bowel Preparation for Magnetic Resonance Enterography	Crohn Disease	Nanjing, China	The Second Hospital of Nanjing Medical University
Microglial Activation in Inflammatory Bowel Disease	Major Depressive Disorder Inflammatory Bowel Disease	Toronto, ON, Canada	Centre for Addiction and Mental Health
Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis Without Nasal Polyps	Chronic Rhinosinusitis	Helsingborg, Sweden	Region Skane
Digestive Microbiota Transplant	Clostridium Difficile Antibiotic Resistant Infection Chronic Diarrhea of Unknown Origin	Marseille, France	Assistance Publique Hopitaux de Marseille
AADC Gene Therapy for Parkinson’s Disease	Parkinson’s Disease	Shimotsuke, Japan	Jichi Medical University
Endoscopic Assessment and Prediction of Microbiome-modifying Interventions	Gut Microbiome Antibiotic Side Effect	Tel Aviv, Israel	Tel-Aviv Sourasky Medical Center
MET-2 Clinical Study for Recurrent Clostridium Difficile Infection	Clostridium Difficile Infection	Kingston, ON, Canada	NuBiyota
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)	Clostridium Difficile Infection	30 locations, USA + Canada	Rebiotix Inc.
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff	Clostridium Difficile Infection Recurrence	34 locations, USA	Finch Research and Development LLC
Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder Who Have Gastrointestinal Disorders	Autism Spectrum Disorder Gastro-Intestinal Disorder	Tempe, AZ, USA	Arizona State University
Diabetes as an Accelerator of Cognitive Impairment and Alzheimer’s Disease	Patients Aged 65-85 (Both Included) Diagnosed of Mild Cognitive Impairment Diagnosed of Type 2 Diabetes in Active Treatment (Hypoglycemic Agents) for a Period of >=5 years	Barcelona, Spain	Parc Sanitari Pere Virgili